Repeatedly negative tuberculin skin tests followed by active tuberculosis in an immunocompetent individual

Netherlands Journal of Medicine

Volumn 58, Issue 2, 2001, Pages 76-81

  Arend, Sandra M ^a   Van Soolingen, Dick ^b   Ottenhoff, Tom H M ^a   Van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Genotyping; Latent tuberculosis infection; Tuberculin skin test

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN;

ADULT; CASE REPORT; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; FEMALE; GENOTYPE; HUMAN; INFECTION; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; TUBERCULIN TEST; TUBERCULOSIS;

ACUTE DISEASE; ADULT; CONTACT TRACING; DIAGNOSIS, DIFFERENTIAL; DISEASE OUTBREAKS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; PREDICTIVE VALUE OF TESTS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 0035144868     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(00)00100-5     Document Type: Conference Paper

References (32)

1. Benefits of screening for latent Mycobacterium tuberculosis infection
2. Community-wide implementation of targeted testing for and treatment of latent tuberculosis infection
3. Targeted tuberculin testing and treatment of latent tuberculosis infection
4. The tuberculin skin test
5. Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses
6. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome
7. Diagnostic standards and classification of tuberculosis in adults and children
8. Tuberculosis in patients with end-stage renal disease
9. Tuberculosis after corticosteroid therapy
10. Tuberculosis in patients with human immunodeficiency virus infection
11. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group
12. An outbreak of mostly extrapulmonary tuberculosis in a family practice
13. Parate kennis over de uitvoering van de Mantoux-test onvoldoende [General knowledge of the performance of Mantoux-test procedure deemed inadequate]
14. Reliability of tuberculin skin test measurement
15. Assessing the validity of tuberculin skin test readings by trained professionals and patients
16. Specificity of the Mantoux-reaction to the new tuberculin RT23 in relation to that of a previously used PPD-RIVM; a comparative study in hospital staff
17. Pseudo-outbreak of tuberculosis infection due to improper skin-test reading [letter]
18. BCG vaccination and the PPD test: what the clinician needs to know
19. BCG and the tuberculin test
20. BCG vaccination and tuberculin testing
21. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis
22. Does aging modify pulmonary tuberculosis?
23. Bacille Calmette-Guérin vaccinations and tuberculin skin tests
24. Reading the tuberculin skin test. Who, when, and how?
25. Significance of the tuberculin test in the elderly
26. Efficacy of BCG vaccine in the prevention of tuberculosis
27. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
28. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
29. Comparative genomics of BCG vaccines by whole-genome DNA microarray
30. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10
31. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10, and those to mixtures of synthetic peptides